Can #chemotherapy be avoided for some patients with breast cancer?
That is exactly what the #NoLEEta trial #GBG121 is investigating. The study focuses on patients with hormone receptor-positive, HER2-negative early breast cancer and an intermediate risk of #recurrence.
